Medline Industries, a leading medical supplies company backed by private equity firms Blackstone, Carlyle, and Hellman & Friedman, has confidentially filed for a U.S. initial public offering (IPO). This move could pave the way for a 2025 listing, potentially valuing the company at up to $50 billion, as reported by Reuters.

If the IPO is successful, it would mark one of the most significant private equity-backed listings in recent years. Although the exact size of the offering is still under discussion, sources indicate that it could raise as much as $5 billion. This would provide a lucrative exit for the private equity firms that acquired Medline in a $34 billion leveraged buyout in 2021, one of the largest deals of its kind in the past decade.

Since the acquisition, the private equity owners have concentrated on enhancing operational efficiencies and identifying growth opportunities to prepare Medline for its public debut. Founded in 1966 and based in Northfield, Illinois, Medline is a major global manufacturer and distributor of medical supplies. Its extensive product range includes surgical equipment, gloves, and laboratory devices that are vital for hospitals and healthcare providers around the world.